SmallCapReview.com is a leading small cap stock information site since 1999, to register for the free SmallCapReview newsletter visit http://www.smallcapreview.com.
Zevotek (Pinksheets: ZVTK) $0.014. Announced after market close the completion of an overseas marketing and sales agreement. The sales agreement shall cover the territories of Germany, Austria, Switzerland, Slovakia, Hungry, Liechtenstein, Romania, Poland and the Czech Republic.
This marks a major venture into the European market for Zevotek. With an infomercial being broadcast into multiple countries and put into several different languages it has more depth then previous given to our products then in earlier sales deals. With their vast experience in the As Seen on TV market we felt this was the best opportunity to gain market share at this juncture.
The agreement calls for 60,000 bulbs over a 12-month period as the foundation of the marketing agreement. As needed, our European partner, in this deal can increase their orders to meet demand. The number of bulbs this deal calls for is only a starting point as we feel that the company Zevotek has chosen to work with, has a strong track record, and will be able to help us gain a foothold in the increasing market of energy efficient lighting. Discussions on the nightlight product were tabled at this time as they have prepared only the standard bulbs infomercial.
What They Do: Zevotek, Inc. plans to market and sell independently a range of distinct and independent lines of home care and household products.
ZAGG Inc. (OTCBB: $2.53) Announced after market close that they will attend the 2009 AeA Micro Cap Financial Conference, as well as present for investors at the J.P. Turner and Company Capital Conference. Robert G. Pedersen II, ZAGG’s President and CEO, will present information for investors at both conferences.
What They Do: ZAGG Inc. designs, manufactures, and distributes protective clear coverings and accessories for consumer electronic and hand-held devices, worldwide under the brand names invisibleSHIELD™ and ZAGGaudio™.
Hydrogen Engine Center (OTCBB: HYEG) $0.14. Announced Tuesday that it will be involved in an $11 million (CAD) hydrogen energy technology demonstration project at Montreal’s Pierre Elliot Trudeau International Airport. The airport project is focused on testing and demonstrating hydrogen technologies and fueling infrastructures. Numerous hydrogen usages will be tested within the project, including but not limited to, passenger transportation, cargo handling, various power sources as well as hydrogen “filling” technologies. A main goal of the project is to demonstrate how hydrogen can be integrated into existing environments safely and effectively.
What They Do: Hydrogen Engine Center, Inc. (HEC) develops systems and processes used in the design, manufacture and distribution of alternative fuel internal combustion engines, engine controls and power generator systems.
Derma Sciences (OTCBB: DSCI) $0.34. Announced Tuesday that on Monday at the annual Symposium on the Advances in Wound Care (SAWC) in Dallas, Jason R. Hanft, DPM, Director of Medical Education at Baptist Health South Florida, revealed details of a recently concluded 11-patient venous leg ulcer (VLU) case series involving the use of Derma Sciences' MEDIHONEY®. Dr. Hanft's presentation was part of the general agenda of the conference, where 24 out of 370 abstracts were selected for oral presentation. In addition, 6 other abstracts dealing with MEDIHONEY were presented at SAWC. SAWC is the largest gathering of multidisciplinary wound-care clinicians in the United States.
What They Do: Derma Sciences is a global manufacturer and marketer of advanced wound care products. Its key product, MEDIHONEY®, is sold throughout the world by Derma Sciences and Comvita New Zealand -- the licensor of the patented honey-based technology -- and is the leading brand of honey-based dressings for the management of wounds and burns.
SmallCapReview.com is not a registered investment advisor or broker/dealer. No investor should assume that reliance on the views, opinions or recommendations contained herein will produce profitable results. Nothing within our site should be construed as an offer or solicitation to buy or sell products or securities. The companies we profile may lack an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. SmallCapReview.com may hold positions in securities mentioned herein, and may make purchases or sales in such securities featured on our website or within our reports. SmallCapReview has been compensated three thousand five hundred dollars by a third party Green Horseshoe for its efforts in profiling Zevotek Inc. SmallCapReview may decide to purchase or sell shares on a voluntary basis in the open market before, during or after the profiling period of this report.
